Importantly, analysis of the RV144 data suggested that the development of nonneutralizing antibody (Ab) responses, including responses to variable region 2 (V2) of HIV Env, and antibody-dependent cellular cytotoxicity (ADCC) were associated with a lower risk of infection (1, –, 4). This evidence concerns the gene ERVW-1 and infection.